Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
July 28, 2021 09:55 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, July 28, 2021 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce it has signed a partnership...
HealthTab™ Adds ID Now™ Molecular Test Device to Abbott Distribution Agreement, Now Offers First Real-time Reporting of SARS-CoV-2, Flu, Strep and RSV System in Pharmacy
July 26, 2021 08:00 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, July 26, 2021 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of the first...
Beta-Testing of New HealthTab™ System in First Shoppers Drug Mart® Pharmacy Performs Well, Shows Strong Patient Demand
July 19, 2021 09:33 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, July 19, 2021 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) announces that patient testing has begun on the first deployment of the new...
Avricore Health CEO Hosts Investor Call July 6th
June 30, 2021 07:00 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, June 30, 2021 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is hosting the first of a regular series of investor calls hosted by the...
First HealthTab™ Testing Success in Shoppers Drug Mart® Pilot Rollout
June 29, 2021 07:00 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, June 29, 2021 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) announces it has successfully launched HealthTab™ in the first of 11...
Amydis Receives $3 Million NIH Commercialization Readiness Pilot Grant Award for Novel Amyloid Beta Retinal Tracer in Cerebral Amyloid Angiopathy
June 28, 2021 07:00 ET
|
Amydis, Inc.
SAN DIEGO, June 28, 2021 (GLOBE NEWSWIRE) -- Amydis Inc., a leading ocular tracer pharmaceutical company with a broad portfolio of diagnostic drug candidates targeting CNS biomarkers in the eye,...
Avricore Health Corporate Update Summer 2021
June 09, 2021 08:00 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, June 09, 2021 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to provide this corporate update on the Company’s successes in...
Avricore Health Signs Master Agreement to Pilot HealthTab™ Platform for Diabetes Management in Select Shoppers Drug Mart® Pharmacies
June 03, 2021 09:30 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, June 03, 2021 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce patients will soon have...
Avricore Health’s HealthTab™ Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
May 31, 2021 08:00 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, May 31, 2021 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a supplier...
Burning Rock Announces the Launch of China’s First Prospective Pan-Cancer Multi-omics Early Detection Study
May 19, 2021 05:06 ET
|
Burning Rock Biotech Limited
BEIJING, May 19, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced the launch of the PRESCIENT (Pan-canceR Early-Stage deteCtion by...